Concepedia

Sandra Van Lint

SV

Statistics

Publications

24

Citations

1.6K

H-Index

20

Active since

2010

Affiliations

Ghent University(Current)

VIB-UGent Center for Medical Biotechnology

Vrije Universiteit Brussel

Centre National de la Recherche Scientifique

Université de Montpellier

Sandra Van Lint is an author at Ghent University specializing in immunology, life sciences, and cancer immunology.

ORCID

Publications per year

2010–2024

24

Publications

24

Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor Therapy

Sandra Van Lint, Cleo Goyvaerts, Sarah Maenhout et al. · Cancer Research · 2012 · 210 citations · Full text

, , +17

Nanoparticle‐Conjugate TLR7/8 Agonist Localized Immunotherapy Provokes Safe Antitumoral Responses

Lutz Nuhn, Stefaan De Koker, Sandra Van Lint et al. · Advanced Materials · 2018 · 160 citations

, , +17

Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes

Lien Van Hoecke, Sandra Van Lint, Kenny Roose et al. · Nature Communications · 2018 · 143 citations · Full text

, , +17

HIV-1 Lentiviral Vector Immunogenicity Is Mediated by Toll-Like Receptor 3 (TLR3) and TLR7

Karine Breckpot, David Escors, Frederick Arce et al. · Journal of Virology · 2010 · 132 citations · Full text

, , +16

Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells

Sandra Van Lint, Dries Renmans, Katrijn Broos et al. · Cancer Immunology Research · 2016 · 128 citations · Full text

, , +17

1–5 of 24